Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Processa Pharmaceuticals ...

    NASDAQ: PCSA · Real-Time Price · USD
    0.33
    0.03 (9.78%)
    At close: Jun 09, 2025, 3:59 PM

    Processa Pharmaceuticals Statistics

    Share Statistics

    Processa Pharmaceuticals has 11.88M shares outstanding. The number of shares has increased by 29.84% in one year.

    Shares Outstanding

    n/a
    		 11.88M

    Shares Change (YoY)

    n/a
    		 29.84%

    Shares Change (QoQ)

    n/a
    		 0.34%

    Owned by Institutions (%)

    n/a
    		 4.19%

    Shares Floating

    n/a
    		 10.44M

    Failed to Deliver (FTD) Shares

    n/a
    		 372

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 703.43K, so 5.92% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 703.43K

    Short % of Shares Out

    n/a
    		 5.92%

    Short % of Float

    n/a
    		 6.2%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.23 and the forward PE ratio is -0.33. Processa Pharmaceuticals's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.23

    Forward PE

    n/a
    		 -0.33

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0

    PB Ratio

    n/a
    		 1.59

    P/FCF Ratio

    n/a
    		 -0.24

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Processa Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.04.

    Current Ratio

    n/a
    		 1.22

    Quick Ratio

    n/a
    		 1.22

    Debt / Equity

    n/a
    		 0.04

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,185,011.8

    Employee Count

    n/a
    		 10

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -81.82% in the last 52 weeks. The beta is 1.37, so Processa Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.37

    52-Week Price Change

    n/a
    		 -81.82%

    50-Day Moving Average

    n/a
    		 0.27

    200-Day Moving Average

    n/a
    		 0.8

    Relative Strength Index (RSI)

    n/a
    		 57.04

    Average Volume (20 Days)

    n/a
    		 4,020,246

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -12.05M

    Net Income

    n/a
    		 -11.85M

    EBITDA

    n/a
    		 -11.85M

    EBIT

    n/a
    		 -11.85M

    Earnings Per Share (EPS)

    n/a
    		 -3.62
    Full Income Statement

    Balance Sheet

    The company has 1.19M in cash and 73.51K in debt, giving a net cash position of 1.12M.

    Cash & Cash Equivalents

    n/a
    		 1.19M

    Total Debt

    n/a
    		 73.51K

    Net Cash

    n/a
    		 1.12M

    Retained Earnings

    n/a
    		 -87.22M

    Total Assets

    n/a
    		 4.81M

    Working Capital

    n/a
    		 2.47M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -11.25M and capital expenditures -3.24K, giving a free cash flow of -11.25M.

    Operating Cash Flow

    n/a
    		 -11.25M

    Capital Expenditures

    n/a
    		 -3.24K

    Free Cash Flow

    n/a
    		 -11.25M

    FCF Per Share

    n/a
    		 -3.68
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    PCSA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for PCSA is $6, which is 1900% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $6

    Price Target Difference

    n/a
    		 1900%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jan 22, 2024. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Jan 22, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -30.25

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist